96. Crohn disease Clinical trials / Disease details
Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04842149 (ClinicalTrials.gov) | May 21, 2021 | 8/4/2021 | The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease | The Effects of Bifidobacterium Breve Bif195 for Small Intestinal Crohn's Disease: a Double-blind, Randomized, Placebo-controlled Study | Crohn Disease | Dietary Supplement: Bif195 capsules;Dietary Supplement: Placebo capsules | Hvidovre University Hospital | Chr Hansen | Recruiting | 18 Years | 75 Years | All | 60 | N/A | Denmark |